ro 31-8220 has been researched along with Kidney Neoplasms in 2 studies
Ro 31-8220: a protein kinase C inhibitor
Kidney Neoplasms: Tumors or cancers of the KIDNEY.
Excerpt | Relevance | Reference |
---|---|---|
"Four renal cell carcinoma (RCC) cell lines were used." | 1.32 | Inhibition of MKP-1 expression potentiates JNK related apoptosis in renal cancer cells. ( Marumo, K; Mizuno, R; Murai, M; Okada, Y; Oya, M; Shiomi, T, 2004) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mizuno, R | 1 |
Oya, M | 1 |
Shiomi, T | 1 |
Marumo, K | 1 |
Okada, Y | 1 |
Murai, M | 1 |
Brenner, W | 1 |
Benzing, F | 1 |
Gudejko-Thiel, J | 1 |
Fischer, R | 1 |
Färber, G | 1 |
Hengstler, JG | 1 |
Seliger, B | 1 |
Thüroff, JW | 1 |
2 other studies available for ro 31-8220 and Kidney Neoplasms
Article | Year |
---|---|
Inhibition of MKP-1 expression potentiates JNK related apoptosis in renal cancer cells.
Topics: Anisomycin; Apoptosis; Carcinoma, Renal Cell; Cell Cycle Proteins; Dual Specificity Phosphatase 1; H | 2004 |
Regulation of beta1 integrin expression by PKCepsilon in renal cancer cells.
Topics: Carcinoma, Renal Cell; CD18 Antigens; Cell Division; Cell Line, Tumor; Cell Movement; Gene Expressio | 2004 |